SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kay Seidel, Josefine Mahlke, Sonny Siswanto, Reijko Krüger, Helmut Heinsen, Georg Auburger, Mohamed Bouzrou, Lea T. Grinberg, Helmut Wicht, Horst-Werner Korf, Wilfred den Dunnen, Udo Rüb, The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies, Brain Pathology, 2015, 25, 1
  2. 2
    Altair B. dos Santos, Kristi A. Kohlmeier, George E. Barreto, Are Sleep Disturbances Preclinical Markers of Parkinson’s Disease?, Neurochemical Research, 2014,

    CrossRef

  3. 3
    Annamaria Capozzo, Flora Vitale, Claudia Mattei, Paolo Mazzone, Eugenio Scarnati, Continuous stimulation of the pedunculopontine tegmental nucleus at 40Hz affects preparative and executive control in a delayed sensorimotor task and reduces rotational movements induced by apomorphine in the 6-OHDA parkinsonian rat, Behavioural Brain Research, 2014, 271, 333

    CrossRef

  4. 4
    Duncan A. A. MacLaren, Joseph A. Santini, Ashley L. Russell, Tamara Markovic, Stewart D. Clark, Deficits in motor performance after pedunculopontine lesions in rats – impairment depends on demands of task, European Journal of Neuroscience, 2014, 40, 8
  5. 5
    Timothy L Tattersall, Peter G Stratton, Terry J Coyne, Raymond Cook, Paul Silberstein, Peter A Silburn, François Windels, Pankaj Sah, Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus, Nature Neuroscience, 2014, 17, 3, 449

    CrossRef

  6. 6
    Kentaro Hirao, Gregory M. Pontone, Gwenn S. Smith, Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease, Neuroscience & Biobehavioral Reviews, 2014,

    CrossRef

  7. 7
    Hokuto Morita, Chris J. Hass, Elena Moro, Atchar Sudhyadhom, Rajeev Kumar, Michael S. Okun, Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?, Frontiers in Neurology, 2014, 5,

    CrossRef

  8. 8
    Jong-Geun Seo, Ho-Won Lee, Sung-Pa Park, Kyunghun Kang, The Interrelations of Quality of Sleep, Depressive Symptoms, and Quality of Life in Idiopathic Parkinson’s Disease, Journal of Korean Sleep Research Society, 2014, 11, 1, 11

    CrossRef

  9. 9
    Glenda M. Halliday, James B. Leverenz, Jay S. Schneider, Charles H. Adler, The neurobiological basis of cognitive impairment in Parkinson's disease, Movement Disorders, 2014, 29, 5
  10. 10
    Altair Brito dos Santos, George E. Barreto, Kristi A. Kohlmeier, Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  11. 11
    Martijn L. T. M. Müller, Nicolaas I. Bohnen, Cholinergic Dysfunction in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2013, 13, 9

    CrossRef

  12. 12
    K. Del Tredici, H. Braak, Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia, Journal of Neurology, Neurosurgery & Psychiatry, 2013, 84, 7, 774

    CrossRef

  13. 13
    Ilse S. Pienaar, Patrick F. Chinnery, Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression, Pharmacology & Therapeutics, 2013, 137, 1, 1

    CrossRef

  14. 14
    Anna Castrioto, Elena Moro, New targets for deep brain stimulation treatment of Parkinson’s disease, Expert Review of Neurotherapeutics, 2013, 13, 12, 1319

    CrossRef

  15. 15
    Etienne C. Hirsch, Peter Jenner, Serge Przedborski, Pathogenesis of Parkinson's disease, Movement Disorders, 2013, 28, 1
  16. 16
    Dagmar Hyacintha Hepp, A.M. Ruiter, Y. Galis, P. Voorn, A.J.M. Rozemuller, H.W. Berendse, E.M.J. Foncke, W.D.J. van de Berg, Pedunculopontine Cholinergic Cell Loss in Hallucinating Parkinson Disease Patients but Not in Dementia With Lewy Bodies Patients, Journal of Neuropathology & Experimental Neurology, 2013, 72, 12, 1162

    CrossRef

  17. 17
    M. L. T. M. Muller, R. L. Albin, V. Kotagal, R. A. Koeppe, P. J. H. Scott, K. A. Frey, N. I. Bohnen, Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease, Brain, 2013, 136, 11, 3282

    CrossRef

  18. 18
    Paolo Mazzone, Stefano Sposato, Angelo Insola, Eugenio Scarnati, The Clinical Effects of Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus in Movement Disorders May Not Be Related to the Anatomical Target, Leads Location, and Setup of Electrical Stimulation, Neurosurgery, 2013, 73, 5, 894

    CrossRef

  19. 19
    W. Thevathasan, A. Pogosyan, J. A. Hyam, N. Jenkinson, T. Foltynie, P. Limousin, M. Bogdanovic, L. Zrinzo, A. L. Green, T. Z. Aziz, P. Brown, Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism, Brain, 2012, 135, 1, 148

    CrossRef

  20. 20
    Mesbah Alam, Hans E. Heissler, Kerstin Schwabe, Joachim K. Krauss, Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model, Experimental Neurology, 2012, 233, 1, 233

    CrossRef

  21. 21
    Paolo Mazzone, Luca Padua, Gianni Falisi, Angelo Insola, Tiziana M. Florio, Eugenio Scarnati, Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus improves oromotor movements in Parkinson’s disease, Brain Stimulation, 2012, 5, 4, 634

    CrossRef

  22. 22
    B.R. Aravamuthan, D.E. Angelaki, Vestibular responses in the macaque pedunculopontine nucleus and central mesencephalic reticular formation, Neuroscience, 2012, 223, 183

    CrossRef

  23. 23
    Yoshikuni Mizuno, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  24. 24
    Heiko Braak, Kelly Del Tredici-Braak, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  25. 25
    Jennifer G Goldman, Christina L Vaughan, Christopher G Goetz, An update expert opinion on management and research strategies in Parkinson's disease psychosis, Expert Opinion on Pharmacotherapy, 2011, 12, 13, 2009

    CrossRef

  26. 26
    Assel Saryyeva, Makoto Nakamura, Joachim K. Krauss, Kerstin Schwabe, c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model, Journal of Chemical Neuroanatomy, 2011, 42, 3, 210

    CrossRef

  27. 27
    Takako Kita, Hitoshi Kita, Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat, European Journal of Neuroscience, 2011, 33, 3
  28. 28
    Feridun Acar, Göksemin Acar, Levent Sinan Bir, Bengi Gedik, Attila Oğuzhanoğlu, Deep Brain Stimulation of the Pedunculopontine Nucleus in a Patient with Freezing of Gait, Stereotactic and Functional Neurosurgery, 2011, 89, 4, 214

    CrossRef

  29. 29
    Jonathan R Evans, Roger A Barker, Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease, Expert Opinion on Pharmacotherapy, 2011, 12, 8, 1249

    CrossRef

  30. 30
    Pietro Caliandro, A. Insola, E. Scarnati, L. Padua, G. Russo, E. Granieri, P. Mazzone, Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson’s disease, Journal of Neural Transmission, 2011, 118, 10, 1477

    CrossRef

  31. 31
    A. H. Snijders, I. Leunissen, M. Bakker, S. Overeem, R. C. Helmich, B. R. Bloem, I. Toni, Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait, Brain, 2011, 134, 1, 59

    CrossRef

  32. 32
    Erlick A. C. Pereira, Dipankar Nandi, Ned Jenkinson, John F. Stein, Alexander L. Green, Tipu Z. Aziz, Pedunculopontine stimulation from primate to patient, Journal of Neural Transmission, 2011, 118, 10, 1453

    CrossRef

  33. 33
    M. U. Ferraye, B. Debû, V. Fraix, P. Krack, S. Charbardès, E. Seigneuret, A.-L. Benabid, P. Pollak, Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?, Journal of Neural Transmission, 2011, 118, 10, 1469

    CrossRef

  34. 34
    Nicolaas I. Bohnen, Roger L. Albin, The cholinergic system and Parkinson disease, Behavioural Brain Research, 2011, 221, 2, 564

    CrossRef

  35. 35
    Alison Yarnall, Lynn Rochester, David J. Burn, The interplay of cholinergic function, attention, and falls in Parkinson's disease, Movement Disorders, 2011, 26, 14
  36. 36
    Eugenio Scarnati, Tiziana Florio, Annamaria Capozzo, Giuseppina Confalone, Paolo Mazzone, The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability, Journal of Neural Transmission, 2011, 118, 10, 1409

    CrossRef

  37. 37
    Iciar Aviles-Olmos, Thomas Foltynie, Jalesh Panicker, Dorothy Cowie, Patricia Limousin, Marwan Hariz, Clare J. Fowler, Ludvic Zrinzo, Urinary incontinence following deep brain stimulation of the pedunculopontine nucleus, Acta Neurochirurgica, 2011, 153, 12, 2357

    CrossRef

  38. 38
    Scellig Stone, Karim Mukhida, Andres M. Lozano, Youmans Neurological Surgery, 2011,

    CrossRef

  39. You have free access to this content39
    Deranda B Lester, Tiffany D. Rogers, Charles D. Blaha, Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders, CNS Neuroscience & Therapeutics, 2010, 16, 3
  40. 40
    Lea Tenenholz Grinberg, Udo Rueb, Ana Tereza di Lorenzo Alho, Helmut Heinsen, Brainstem pathology and non-motor symptoms in PD, Journal of the Neurological Sciences, 2010, 289, 1-2, 81

    CrossRef

  41. 41
    Carine Karachi, David Grabli, Frédéric A. Bernard, Dominique Tandé, Nicolas Wattiez, Hayat Belaid, Eric Bardinet, Annick Prigent, Hans-Peter Nothacker, Stéphane Hunot, Andreas Hartmann, Stéphane Lehéricy, Etienne C. Hirsch, Chantal François, Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease, Journal of Clinical Investigation, 2010, 120, 8, 2745

    CrossRef

  42. 42
    A. Peppe, M. Pierantozzi, C. Chiavalon, F. Marchetti, C. Caltagirone, M. Musicco, P. Stanzione, A. Stefani, Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: Effects on gait in Parkinson's disease, Gait & Posture, 2010, 32, 4, 512

    CrossRef

  43. 43
    Felix Rauch, Kerstin Schwabe, Joachim K. Krauss, Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model, Behavioural Brain Research, 2010, 210, 1, 46

    CrossRef

  44. 44
    M. U. Ferraye, B. Debu, V. Fraix, L. Goetz, C. Ardouin, J. Yelnik, C. Henry-Lagrange, E. Seigneuret, B. Piallat, P. Krack, J.-F. Le Bas, A.-L. Benabid, S. Chabardes, P. Pollak, Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease, Brain, 2010, 133, 1, 205

    CrossRef

  45. 45
    Daniel R. Andersson, Evelina Björnsson, Filip Bergquist, Hans Nissbrandt, Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors, Experimental Neurology, 2010, 221, 1, 251

    CrossRef

  46. 46
    Stefani Alessandro, Roberto Ceravolo, Livia Brusa, Mariangela Pierantozzi, Alberto Costa, Salvatore Galati, Fabio Placidi, Andrea Romigi, Cesare Iani, Francesco Marzetti, Antonella Peppe, Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: Focus on sleep and cognitive domains, Journal of the Neurological Sciences, 2010, 289, 1-2, 44

    CrossRef

  47. 47
    David H. Benninger, Jan Michel, Daniel Waldvogel, Victor Candia, Rositsa Poryazova, Hubertus J.A. van Hedel, Claudio L. Bassetti, REM sleep behavior disorder is not linked to postural instability and gait dysfunction in Parkinson, Movement Disorders, 2010, 25, 11
  48. 48
    Romulo Fuentes, Per Petersson, Miguel A. L. Nicolelis, Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach, European Journal of Neuroscience, 2010, 32, 7
  49. 49
    I-Jin Yeh, Eric W. Tsang, Clement Hamani, Elena Moro, Filomena Mazzella, Yu-Yan Poon, Andres M. Lozano, Robert Chen, Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region, Movement Disorders, 2010, 25, 13
  50. 50
    M.-U. Ferraye, B. Debû, P. Pollak, Stimulation cérébrale profonde et troubles de la marche dans la maladie de Parkinson, Revue Neurologique, 2010, 166, 2, 178

    CrossRef

  51. 51
    Glenda Halliday, Karen Murphy, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  52. 52
    Simon J.G. Lewis, Roger A. Barker, A pathophysiological model of freezing of gait in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 5, 333

    CrossRef

  53. 53
    John F. Stein, Akinesia, motor oscillations and the pedunculopontine nucleus in rats and men, Experimental Neurology, 2009, 215, 1, 1

    CrossRef

  54. 54
    Ned Jenkinson, Dipanker Nandi, Kalai Muthusamy, Nicola J. Ray, Ralph Gregory, John F. Stein, Tipu Z. Aziz, Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus, Movement Disorders, 2009, 24, 3
  55. 55
    Annamaria Capozzo, Tiziana Florio, Giuseppina Confalone, Daniela Minchella, Paolo Mazzone, Eugenio Scarnati, Low frequency stimulation of the pedunculopontine nucleus modulates electrical activity of subthalamic neurons in the rat, Journal of Neural Transmission, 2009, 116, 1, 51

    CrossRef

  56. 56
    S.J. van Albada, P.A. Robinson, Mean-field modeling of the basal ganglia-thalamocortical system. I, Journal of Theoretical Biology, 2009, 257, 4, 642

    CrossRef

  57. 57
    S.J. van Albada, R.T. Gray, P.M. Drysdale, P.A. Robinson, Mean-field modeling of the basal ganglia-thalamocortical system. II, Journal of Theoretical Biology, 2009, 257, 4, 664

    CrossRef

  58. 58
    Young-Hee Sung, Ki-Hyung Park, Yeung-Bae Lee, Hyeon-Mi Park, Dong Jin Shin, Jea-Sul Park, Mi-Sun Oh, Hyeo-Il Ma, Kyung-Ho Yu, Suk-Yun Kang, Yun Joong Kim, Byung-Chul Lee, Midbrain atrophy in subcortical ischemic vascular dementia, Journal of Neurology, 2009, 256, 12, 1997

    CrossRef

  59. 59
    Simon J.G. Lewis, Roger A. Barker, Understanding the dopaminergic deficits in Parkinson’s disease: Insights into disease heterogeneity, Journal of Clinical Neuroscience, 2009, 16, 5, 620

    CrossRef

  60. 60
    E. P. Lukhanina, N. A. Mel’nik, N. M. Berezetskaya, I. N. Karaban’, Correlations between indices of P300 EEG potential, cognitive tests, and variational pulsometry in Parkinsonian patients, Neurophysiology, 2008, 40, 1, 39

    CrossRef

  61. 61
    T.Z. Aziz, J.F. Stein, Editorial commentary: Oscillatory activity and deep brain stimulation in the pedunculopontine nucleus, Experimental Neurology, 2008, 212, 2, 247

    CrossRef

  62. 62
    J.E. Visser, J.H.J. Allum, M.G. Carpenter, R.A.J. Esselink, P. Limousin-Dowsey, F. Honegger, G.F. Borm, B.R. Bloem, Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease, Neuroscience, 2008, 157, 4, 798

    CrossRef

  63. 63
    Michael S Remple, Yaw Sarpong, Joseph S Neimat, Frontiers in the surgical treatment of Parkinson’s disease, Expert Review of Neurotherapeutics, 2008, 8, 6, 897

    CrossRef

  64. 64
    Olga V. Poisik, Jian-xin Shen, Susan Jones, Jerrel L. Yakel, Functional α7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata, The Journal of Physiology, 2008, 586, 5
  65. 65
    Laurie A. King, Fay B. Horak, Lateral Stepping for Postural Correction in Parkinson’s Disease, Archives of Physical Medicine and Rehabilitation, 2008, 89, 3, 492

    CrossRef

  66. 66
    Juha O. Rinne, Shuang Yong Ma, Myung Sik Lee, Yrjö Collan, Matias Röyttä, Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients, Parkinsonism & Related Disorders, 2008, 14, 7, 553

    CrossRef

  67. 67
    Deranda B. Lester, Anthony D. Miller, Tiffany D. Pate, Charles D. Blaha, Midbrain acetylcholine and glutamate receptors modulate accumbal dopamine release, NeuroReport, 2008, 19, 9, 991

    CrossRef

  68. 68
    Moran Weinberger, Clement Hamani, William D. Hutchison, Elena Moro, Andres M. Lozano, Jonathan O. Dostrovsky, Pedunculopontine nucleus microelectrode recordings in movement disorder patients, Experimental Brain Research, 2008, 188, 2, 165

    CrossRef

  69. 69
    L. Zrinzo, L. V. Zrinzo, S. Tisch, P. D. Limousin, T. A. Yousry, F. Afshar, M. I. Hariz, Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization, Brain, 2008, 131, 6, 1588

    CrossRef

  70. 70
    Klaus Jahn, Angela Deutschländer, Thomas Stephan, Roger Kalla, Katharina Hüfner, Judith Wagner, Michael Strupp, Thomas Brandt, Using Eye Movements as an Experimental Probe of Brain Function - A Symposium in Honor of Jean Büttner-Ennever, 2008,

    CrossRef

  71. 71
    Leonard Petrucelli, Dennis W. Dickson, Parkinson's Disease, 2008,

    CrossRef

  72. 72
    M. Gomez-Gallego, E. Fernandez-Villalba, A. Fernandez-Barreiro, M. T. Herrero, Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression, Journal of Neural Transmission, 2007, 114, 3, 319

    CrossRef

  73. 73
    Tiziana Florio, Eugenio Scarnati, Giuseppina Confalone, Daniela Minchella, Salvatore Galati, Paolo Stanzione, Alessandro Stefani, Paolo Mazzone, High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat, European Journal of Neuroscience, 2007, 25, 4
  74. 74
    Christopher Kenney, Hubert H Fernandez, Michael S Okun, Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson’s disease, Expert Review of Neurotherapeutics, 2007, 7, 6, 585

    CrossRef

  75. 75
    Clement Hamani, Scellig Stone, Adrian Laxton, Andres M. Lozano, The pedunculopontine nucleus and movement disorders: Anatomy and the role for deep brain stimulation, Parkinsonism & Related Disorders, 2007, 13, S276

    CrossRef

  76. 76
    Jayaraman Rao, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  77. 77
    Claire Henchcliffe, M. Flint Beal, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  78. 78
    Claudia Trenkwalder, Birgit Högl, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  79. 79
    Guido Alves, Jan Petter Larsen, Murat Emre, Tore Wentzel-Larsen, Dag Aarsland, Changes in motor subtype and risk for incident dementia in Parkinson's disease, Movement Disorders, 2006, 21, 8
  80. 80
    S. Lubik, W. Fogel, V. Tronnier, M. Krause, J. König, W. H. Jost, Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation, Journal of Neural Transmission, 2006, 113, 2, 163

    CrossRef

  81. 81
    S. Breit, L. Lessmann, D. Unterbrink, R. C. Popa, T. Gasser, J. B. Schulz, Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model, European Journal of Neuroscience, 2006, 24, 8
  82. 82
    K. Wakabayashi, F. Mori, H. Takahashi, Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease, Parkinsonism & Related Disorders, 2006, 12, S92

    CrossRef

  83. 83
    Christian Duval, Michel Panisset, Antonio P. Strafella, Abbas F. Sadikot, The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson’s disease, Experimental Brain Research, 2006, 170, 2, 160

    CrossRef

  84. 84
    D. Nandi, N. Jenkinson, J.F. Stein, T.Z. Aziz, Brainstem Function and Dysfunction, 2006,

    CrossRef

  85. 85
    A. Perrotta, M. Serrao, M. Bartolo, L. Valletta, N. Locuratolo, F. Pujia, F. Fattapposta, P. Bramanti, G.A. Amabile, F. Pierelli, L. Parisi, Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease, Clinical Neurophysiology, 2005, 116, 9, 2091

    CrossRef

  86. 86
    Claire E Heise, Zui Chih Teo, Bradley A Wallace, Keyoumars Ashkan, Alim-Louis Benabid, John Mitrofanis, Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?, Anatomy and Embryology, 2005, 210, 4, 287

    CrossRef

  87. 87
    J. Eric Ahlskog, Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease, Movement Disorders, 2005, 20, 3
  88. 88
    P. H. Lee, S. W. Yong, Y. H. Ahn, K. Huh, Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus, Journal of Neurology, 2005, 252, 8, 958

    CrossRef

  89. 89
    M. Ferrarin, M. Rizzone, B. Bergamasco, M. Lanotte, M. Recalcati, A. Pedotti, L. Lopiano, Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson?s disease, Experimental Brain Research, 2005, 160, 4, 517

    CrossRef

  90. 90
    Mai T. Dang, Fumiaki Yokoi, Kevin St. P. McNaught, Toni-Ann Jengelley, Tehone Jackson, Jianyong Li, Yuqing Li, Generation and characterization of Dyt1 ΔGAG knock-in mouse as a model for early-onset dystonia, Experimental Neurology, 2005, 196, 2, 452

    CrossRef

  91. 91
    Francesco Fornai, Paola Soldani, Gloria Lazzeri, Adolfo Bandettini di Poggio, Francesca Biagioni, Federica Fulceri, Serena Batini, Stefano Ruggieri, Antonio Paparelli, Neuronal inclusions in degenerative disorders, Brain Research Bulletin, 2005, 65, 4, 275

    CrossRef

  92. 92
    Masaru Matsumura, The pedunculopontine tegmental nucleus and experimental parkinsonism, Journal of Neurology, 2005, 252, S4, iv5

    CrossRef

  93. 93
    S. Breit, L. Lessmann, A. Benazzouz, J. B. Schulz, Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat, European Journal of Neuroscience, 2005, 22, 9
  94. 94
    Claudia Trenkwalder, Principles and Practice of Sleep Medicine, 2005,

    CrossRef

  95. 95
    Kevin St. P. McNaught, Alexander Kapustin, Tehone Jackson, Toni-Ann Jengelley, Ruth JnoBaptiste, Pullanipally Shashidharan, Daniel P. Perl, Pedro Pasik, C. Warren Olanow, Brainstem pathology in DYT1 primary torsion dystonia, Annals of Neurology, 2004, 56, 4
  96. 96
    Simon Lemay, Sylvain Chouinard, Pierre Blanchet, Hélène Masson, Valérie Soland, Anne Beuter, Marc-André Bédard, Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004, 28, 1, 31

    CrossRef

  97. 97
    Anthony D. Miller, Charles D. Blaha, Nigrostriatal dopamine release modulated by mesopontine muscarinic receptors, NeuroReport, 2004, 15, 11, 1805

    CrossRef

  98. 98
    Juan Mena-Segovia, J. Paul Bolam, Peter J. Magill, Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family?, Trends in Neurosciences, 2004, 27, 10, 585

    CrossRef

  99. 99
    Ned Jenkinson, Dipankar Nandi, R. Chris Miall, John F. Stein, Tipu Z. Aziz, Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey, NeuroReport, 2004, 15, 17, 2621

    CrossRef

  100. 100
    JLW Bosboom, ECh Wolters, Psychotic symptoms in Parkinson’s disease: pathophysiology and management, Expert Opinion on Drug Safety, 2004, 3, 3, 209

    CrossRef

  101. 101
    K. Takakusaki, K. Saitoh, H. Harada, M. Kashiwayanagi, Role of basal ganglia–brainstem pathways in the control of motor behaviors, Neuroscience Research, 2004, 50, 2, 137

    CrossRef

  102. 102
    Mi Fa Jeon, Yoon Ha, Yoon Hee Cho, Bae Hwan Lee, Yong Gou Park, Jin Woo Chang, Effect of ipsilateral subthalamic nucleus lesioning in a rat parkinsonian model: study of behavior correlated with neuronal activity in the pedunculopontine nucleus, Journal of Neurosurgery, 2003, 99, 4, 762

    CrossRef

  103. 103
    Margaret A. Piggott, Jonathan Owens, John O'Brien, Sean Colloby, John Fenwick, David Wyper, Evelyn Jaros, Mary Johnson, Robert H. Perry, Elaine K. Perry, Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease, Journal of Chemical Neuroanatomy, 2003, 25, 3, 161

    CrossRef

  104. 104
    Gina L. Forster, Charles D. Blaha, Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat, European Journal of Neuroscience, 2003, 17, 4
  105. 105
    Matthew A. Brodsky, James Godbold, Tom Roth, C. Warren Olanow, Sleepiness in Parkinson's disease: A controlled study, Movement Disorders, 2003, 18, 6
  106. 106
    Ergun Y. Uc, Robert D. Skinner, Robert L. Rodnitzky, Edgar Garcia-Rill, The midlatency auditory evoked potential P50 is abnormal in Huntington's disease, Journal of the Neurological Sciences, 2003, 212, 1-2, 1

    CrossRef

  107. 107
    Nicole Duchesne, Jean-Paul Soucy, H??l??ne Masson, Sylvain Chouinard, Marc-Andr?? B??dard, Cognitive Deficits and Striatal Dopaminergic Denervation in Parkinson's Disease: A Single Photon Emission Computed Tomography Study Using 123Iodine-??-CIT in Patients ON and OFF Levodopa, Clinical Neuropharmacology, 2002, 25, 4, 216

    CrossRef

  108. 108
    Dipankar Nandi, Xuguang Liu, Jonathan L. Winter, Tipu Z. Aziz, John F. Stein, Deep brain stimulation of the pedunculopontine region in the normal non-human primate, Journal of Clinical Neuroscience, 2002, 9, 2, 170

    CrossRef

  109. 109
    G.L Forster, A.J Falcon, A.D Miller, G.A Heruc, C.D Blaha, Effects of laterodorsal tegmentum excitotoxic lesions on behavioral and dopamine responses evoked by morphine and d-amphetamine, Neuroscience, 2002, 114, 4, 817

    CrossRef

  110. 110
    J.N Joyce, H.L Ryoo, T.B Beach, J.N Caviness, Mark Stacy, E.V Gurevich, Mark Reiser, C.H Adler, Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors, Brain Research, 2002, 955, 1-2, 138

    CrossRef

  111. 111
    I Eisensehr, H v Lindeiner, M Jäger, S Noachtar, REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography?, Journal of the Neurological Sciences, 2001, 186, 1-2, 7

    CrossRef

  112. 112
    Tamar Shochat, Jose Loredo, Sonia Ancoli-Israel, Sleep disorders in the elderly, Current Treatment Options in Neurology, 2001, 3, 1, 19

    CrossRef

  113. 113
    Sorin Breit, Rabia Bouali-Benazzouz, Alim-Louis Benabid, Abdelhamid Benazzouz, Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat, European Journal of Neuroscience, 2001, 14, 11
  114. 114
    Jeffrey N. Joyce, Functional Neurobiology of Aging, 2001,

    CrossRef

  115. 115
    Gina L. Forster, Charles D. Blaha, Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area, European Journal of Neuroscience, 2000, 12, 10
  116. 116
    Etienne C. Hirsch, Céline Périer, Gaël Orieux, Chantal François, Jean Féger, Jér⩽ ome Yelnik, Miquel Vila, Richard Levy, Eduardo S. Tolosa, Concepcio Marin, M. Trinidad Herrero, José A. Obeso, Yves Agid, Metabolic effects of nigrostriatal denervation in basal ganglia, Trends in Neurosciences, 2000, 23, S78

    CrossRef

  117. 117
    M Matsumura, A Nambu, Y Yamaji, K Watanabe, H Imai, M Inase, H Tokuno, M Takada, Organization of somatic motor inputs from the frontal lobe to the pedunculopontine tegmental nucleus in the macaque monkey, Neuroscience, 2000, 98, 1, 97

    CrossRef

  118. 118
    M. Takada, M. Matsumura, J. Kojima, Y. Yamaji, M. Inase, H. Tokuno, A. Nambu, H. Imai, Protection against dopaminergic nigrostriatal cell death by excitatory input ablation, European Journal of Neuroscience, 2000, 12, 5
  119. 119
    M.A. Bédard, B. Pillon, B. Dubois, N. Duchesne, H. Masson, Y. Agid, Acute and Long-Term Administration of Anticholinergics in Parkinson's Disease: Specific Effects on the Subcortico-Frontal Syndrome, Brain and Cognition, 1999, 40, 2, 289

    CrossRef

  120. 120
    T. C. Wetter, V. Collado-Seidel, Claudia Trenkwalder, Polysomnographische Untersuchungen von Patienten mit Parkinson-Syndrome im Vergleich zu gesunden Kontrollen, Somnologie - Schlafforschung und Schlafmedizin, 1999, 3, 6, 300

    CrossRef

  121. 121
    K.F Manaye, R Zweig, D Wu, L.B Hersh, S De Lacalle, C.B Saper, D.C German, Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain, Neuroscience, 1999, 89, 3, 759

    CrossRef

  122. 122
    Ikuko Nagatsu, Keiko Ikemoto, Terumi Takeuchi, Ryohachi Arai, Nobuyuki Karasawa, Tetsuya Fujii, Toshiharu Nagatsu, Phenylethanolamine-N-methyltransferase – immunoreactive nerve terminals afferent to the mouse substantia nigra, Neuroscience Letters, 1998, 245, 1, 41

    CrossRef

  123. 123
    Charles Teo, Lisa Rasco, Kynda Al-Mefty, Robert D. Skinner, Frederick A. Boop, Edgar Garcia-Rill, Decreased habituation of midlatency auditory evoked responses in parkinson's disease, Movement Disorders, 1997, 12, 5
  124. 124
    Masaru Matsumura, Katsushige Watanabe, Chihiro Ohye, Single-unit activity in the primate nucleus tegmenti pedunculopontinus related to voluntary arm movement, Neuroscience Research, 1997, 28, 2, 155

    CrossRef

  125. 125
    S. De Lacalle, C.B. Saper, The Primate Nervous System, Part I, 1997,

    CrossRef

  126. 126
    André Parent, Pierre-Yves Côté, Brigitte Lavoie, Chemical anatomy of primate basal ganglia, Progress in Neurobiology, 1995, 46, 2-3, 131

    CrossRef

  127. 127
    R. P. Iacono, R. R. Lonser, G. Maeda, S. Kuniyoshi, D. Warner, G. Mandybur, Sh. Yamada, Chronic anterior pallidal stimulation for parkinson's disease, Acta Neurochirurgica, 1995, 137, 1-2, 106

    CrossRef

  128. 128
    Philippe Anglade, France Javoy-Agid, Yves AgidM, Etienne C. Hirsch, Shigeru Tsuji, Plasticity of nerve afferents to nigrostriatal neurons in parkinson's disease, Annals of Neurology, 1995, 37, 2
  129. 129
    Robert P. Iacono, Fumio Shima, Russell R. Lonser, Sandra Kuniyoshi, George Maeda, Shokei Yamada, The Results, Indications, and Physiology of Posteroventral Pallidotomy for Patients with Parkinson??s Disease, Neurosurgery, 1995, 36, 6, 1118???1127

    CrossRef

  130. 130
    Robert P. Iacono, Fumio Shima, Russell R. Lonser, Sandra Kuniyoshi, George Maeda, Shokei Yamada, The Results, Indications, and Physiology of Posteroventral Pallidotomy for Patients with Parkinsonʼs Disease, Neurosurgery, 1995, 36, 6, 1118

    CrossRef

  131. 131
    Steven R. Vincent, Nitric Oxide in the Nervous System, 1995,

    CrossRef

  132. 132
    D. Curti, E. Izzo, G. Benzi, Alteration of pallidal cholinergic activity in MPTP-treated monkeys: Effect of dihydro-α-ergocryptine (DEK), Neuroscience Letters, 1994, 168, 1-2, 213

    CrossRef

  133. 133
    W.L. Inglis, L.F. Allen, R.B. Whitelaw, M.P. Latimer, H.M. Brace, P. Winn, An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and apomorphine in the rat, Neuroscience, 1994, 58, 4, 817

    CrossRef

  134. 134
    Ali Charara, Andre´ Parent, Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey, Brain Research, 1994, 640, 1-2, 155

    CrossRef

  135. 135
    R. P. Iacono, R. R. Lonser, Sh. Yamada, Contemporaneous bilateral postero-ventral pallidotomy for early onset “juvenile type” Parkinson's disease. Case report, Acta Neurochirurgica, 1994, 131, 3-4, 247

    CrossRef

  136. 136
    Brigitte Lavoie, André Parent, Pedunculopontine nucleus in the squirrel monkey: Cholinergic and glutamatergic projections to the substantia nigra, Journal of Comparative Neurology, 1994, 344, 2
  137. 137
    Thomas Sleekier, Wendy Inglis, Philip Winn, Arjun Sahgal, The pedunculopontine tegmental nucleus: a role in cognitive processes?, Brain Research Reviews, 1994, 19, 3, 298

    CrossRef

  138. 138
    Mark D. Kelland, Arthur S. Freeman, Janet Rubin, Louis A. Chiodo, Ascending afferent regulation of rat midbrain dopamine neurons, Brain Research Bulletin, 1993, 31, 5, 539

    CrossRef

  139. 139
    A. P. Fève, G. Fénelon, C. Wallays, P. Rémy, A. Guillard, Axial motor disturbances after hypoxic lesions of the globus pallidus, Movement Disorders, 1993, 8, 3
  140. 140
    M.T. Herrero, E.C. Hirsch, F. Javoy-Agid, J.A. Obeso, Y. Agid, Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum, Brain Research, 1993, 624, 1-2, 281

    CrossRef

  141. 141
    W.-P. Gai, L. B. Geffen, L. Denoroy, W. W. Blessing, Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in parkinson's disease, Annals of Neurology, 1993, 33, 4
  142. 142
    Masayuki Shintaku, Neuronal Loss in the Pedunculopontine Tegmental Nucleus Ipsilateral to a Massive Cerebral Infarct, Neuropathology, 1993, 13, 3
  143. 143
    Pierre-Yves Côté, André Parent, Calbindin D-28k and choline acetyltransferase are expressed by different neuronal populations in pedunculopontine nucleus but not in nucleus basalis in squirrel monkeys, Brain Research, 1992, 593, 2, 245

    CrossRef

  144. 144
    Tipu Z. Aziz, David Peggs, Elisabeth Agarwal, Michael A. Sambrook, Alan R. Crossman, Subthalamic nucleotomy alleviates parkinsonism in the 1 -methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-exposed primate, British Journal of Neurosurgery, 1992, 6, 6, 575

    CrossRef

  145. 145
    Peter V. Rabins, Handbook of Mental Health and Aging, 1992,

    CrossRef

  146. 146
    Irena Grofova, Sheila Keane, Descending brainstem projections of the pedunculopontine tegmental nucleus in the rat, Anatomy and Embryology, 1991, 184, 3, 275

    CrossRef

  147. 147
    F. Dellu, W. Mayo, J. Cherkaoui, M. Le Moal, H. Simon, Learning disturbances following excitotoxic lesion of cholinergic pedunculo-pontine nucleus in the rat, Brain Research, 1991, 544, 1, 126

    CrossRef

  148. 148
    T. Z. Aziz, D. Peggs, M. A. Sambrook, A. R. Crossman, Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate, Movement Disorders, 1991, 6, 4
  149. 149
    Bryan M. Spann, Irena Grofova, Nigropedunculopontine projection in the rat: An Anterograde tracing study with phaseolus vulgaris-leucoagglutinin (PHA-L), Journal of Comparative Neurology, 1991, 311, 3
  150. 150
    Kurt A. Jellinger, Pathology of Parkinson’s disease, Molecular and Chemical Neuropathology, 1991, 14, 3, 153

    CrossRef

  151. 151
    Craig N. Karson, Edgar Garcia-Rill, JoAnn Biedermann, Robert E. Mrak, Muhammad M. Husain, Robert D. Skinner, The brain stem reticular formation in schizophrenia, Psychiatry Research: Neuroimaging, 1991, 40, 1, 31

    CrossRef

  152. 152
    P.D. Griffiths, M.A. Sambrook, R. Perry, A.R. Crossman, Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease, Journal of the Neurological Sciences, 1990, 100, 1-2, 131

    CrossRef

  153. 153
    G. M. Halliday, Y. W. Li, P. C. Blumbergs, T. H. Joh, R. G. H. Cotton, P. R. C. Howe, W. W. Blessing, L. B. Geffen, Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease, Annals of Neurology, 1990, 27, 4
  154. 154
    G.M. Halliday, W.P. Gai, W.W. Blessing, L.B. Geffen, Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain, Neuroscience, 1990, 39, 1, 81

    CrossRef

  155. 155
    Carlos Juri, Maria C. Rodriguez-Oroz, Jose A. Obeso, Functional Organization of the Basal Ganglia: Dopaminergic and Non-Dopaminergic Features,
  156. 156
    Yvette A. M. Grimbergen, Arlène D. Speelman, Marjolein A. van der Marck, Yvonne Schoon, Bastiaan R. Bloem, Gait, Postural Instability, and Freezing,
  157. 157
    Heiko Braak, Kelly Del Tredici, Non-Dopaminergic Pathology of Parkinson's Disease,